PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

$21.02
+0.02 (+0.10%)
As of Apr 1, 3:20 PM ET ·
Financial Highlights (FY 2025)
Revenue
12.22M
Net Income
1.67M
Gross Margin
34.6%
Profit Margin
13.7%
Rev Growth
+12.4%
D/E Ratio
0.63
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 34.6% 34.6% 34.6%
Operating Margin 15.6% 18.3% 16.9%
Profit Margin 13.7% 13.1% 13.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.22M 12.16M 13.52M
Gross Profit 4.22M 4.20M 4.67M
Operating Income 1.91M 2.23M 2.28M
Net Income 1.67M 1.59M 1.78M
Gross Margin 34.6% 34.6% 34.6%
Operating Margin 15.6% 18.3% 16.9%
Profit Margin 13.7% 13.1% 13.2%
Rev Growth +12.4% +20.7% +15.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 35.24M 30.53M 34.79M
Total Equity 56.05M 48.64M 50.50M
D/E Ratio 0.63 0.63 0.69
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.79M 3.00M 3.51M
Free Cash Flow 1.30M 1.27M 1.44M